Evidence map›Paper›PMID 40889205›Full record

ArticleJournal of cellular and molecular medicine2025

Monitoring SARS-CoV-2 Dissemination in Wastewater and Virus Isolation in Cell Cultures: An Integrated Approach for Pathogen Detection and Surveillance.

Elena Radu, Tudor Emanuel Fertig, Laura Denisa Dragu, Ioana Mădălina Pitică, Marius Surleac, Ana Iulia Neagu, Lavinia Pană, Alexandra Păiş, Lilia Matei, Ionut-Lucian Antone-Iordache and 17 more

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Elena RaduDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.ORCID 0000-0001-5839-5605
Tudor Emanuel FertigCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Laura Denisa DraguDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Ioana Mădălina PiticăDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Marius SurleacResearch Institute of the University of Bucharest-ICUB, University of Bucharest, Bucharest, Romania.
Ana Iulia NeaguDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Lavinia PanăDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Alexandra PăişDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Lilia MateiDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Ionut-Lucian Antone-IordacheCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.ORCID 0009-0005-7771-1606
Daciana Silvia MartaUltrastructural Pathology and Bioimaging Lab, Victor Babeș National Institute of Pathology, Bucharest, Romania.
Victor-Eduard PeteuUltrastructural Pathology and Bioimaging Lab, Victor Babeș National Institute of Pathology, Bucharest, Romania.ORCID 0000-0002-4264-3739
Mihai Niţă-LazărNational Research and Development Institute for Industrial Ecology (ECOIND), Bucharest, Romania.
Cătălina StoicaNational Research and Development Institute for Industrial Ecology (ECOIND), Bucharest, Romania.
Cornel PopescuCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Camelia Mădălina SultanaDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Anca BotezatuDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.ORCID 0000-0002-1502-9733
Iulia Virginia IancuDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Mihaela Chivu-EconomescuDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Leontina BanicăCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Ana Sorinica PetreApa Nova WasteWater Treatment Plant Directorate, Bucharest, Romania.
Simona ParaschivCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Mihaela GherghiceanuCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Simona Maria RutaDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Norbert KreuzingerInstitute for Water Quality and Resource Management, Vienna University of Technology, Vienna, Austria.
Carmen Cristina DiaconuDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.ORCID 0000-0002-2259-1425
Coralia BleotuDepartment of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.ORCID 0000-0002-9031-338X

Funding

CNCS-UEFISCDI, PN-III-P2-2.1-PED-2021-4131 705PED/2022 PED-2021-4131 705PED/2022The Ministry of Investments and European Projects, through the Managing Authority for the Health Program, PS/272/PS_P5/OP1/RSO1.1/PS_P5_RSO1.1_A9-ROGEN Project (SMIS 324809) SMIS 324809
6 · The paper itself

Abstract

Our study presents wastewater (WW) monitoring data, focusing on determining the infectivity of SARS-CoV-2 in the collected samples. Additionally, a panel of different viruses has been tested in the WW samples. The untreated WW monitoring campaign took place over 1 year in Bucharest, with approximately 300 samples being collected twice a week at the wastewater treatment plant (WWTP) and an infectious diseases hospital. Our data indicated that SARS-CoV-2 concentrations in WW preceded the increase in the number of clinical cases by nearly 2 weeks. Differences between locations were notable, with higher raw concentrations in WW samples from the hospital than those from the WWTP. However, after normalising to population equivalent, the hospital samples concentrations dropped significantly, suggesting that WW monitoring at the urban level provides a more complete and epidemiologically relevant picture than data obtained only from hospitals. Only a few isolates could demonstrate SARS-CoV-2 persistence during in vitro passages. Although the success rate was low, the technique remains crucial for validating the viability of viruses. Adenovirus, Bocavirus and Reovirus were the most abundant ones in both urban and hospital wastewater. WW monitoring remains the most effective approach for tracking the dissemination of various pathogens and supporting public health authorities.

Indexed as

COVID-19SARS-CoV-2WastewaterHospitalsHumansWastewaterenvironmental surveillanceSARS‐CoV‐2 infectivityvirus isolationwastewater monitoring

Identifiers

PMID40889205
PMCPMC12401128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.